-
December 3: The Week in Cancer News
Some cancer centers scrutinized for lack of pricing transparency, and an imaging drug helps surgeons better identify ovarian cancer with fluorescent lighting.
by Marci A. Landsmann
-
November 19: The Week in Cancer News
HPV vaccine rates are higher when teens decide, and colorectal cancer is on the rise in people under 50.
by Kevin McLaughlin
-
November 12: The Week in Cancer News
The U.S. Is behind the U.K. in preventing cervical cancer through HPV vaccination, and lack of health insurance impacts cancer screening in the unemployed.
by Eric Fitzsimmons
-
November 5: The Week in Cancer News
U.S. map spotlights industrial hot spots for cancer-causing air pollution, and surgery delays after initial treatment impact survival for some patients with locally advanced rectal cancer.
by Marci A. Landsmann
-
October 29: The Week in Cancer News
Patient expenses for cancer care exceed $21 billion in 2019, and the FDA introduces stringent requirements for breast implants.
by Kevin McLaughlin
-
October 22: The Week in Cancer News
Researchers suggest Black women should be screened for breast cancer at age 40, and a couple reflect on how a cancer diagnosis affected their adoption journey.
by Bradley Jones
-
October 15: The Week in Cancer News
FDA authorizes electronic cigarette for the first time, and a new survey explores marijuana use in breast cancer patients
by Eric Fitzsimmons
-
October 8: The Week in Cancer News
A study shows the cost of drugs that manage cancer-related symptoms adds up, and experts explore research at the AACR conference on cancer disparities.
by Marci A. Landsmann
-
October 1: The Week in Cancer News
MRI can be a cost-effective way to screen for breast cancer, and a new study investigates the impact of higher alcohol taxes on cancer incidence
by Kevin McLaughlin
-
September 24: The Week in Cancer News
Long-term COVID-19 effects were associated with greater mortality risk in cancer patients, and a new study compares HER2-targeted therapies in metastatic breast cancer.
by Eric Fitzsimmons
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore